Related Experiment Videos
Mutations in the WRN gene in mice accelerate mortality in a p53-null background
D B Lombard1, C Beard, B Johnson
1Department of Biology, Massachusetts Institute of Technology, Boston, Massachusetts, USA.
Molecular and Cellular Biology
|April 11, 2000
Summary
This study generated mice with a WRN gene mutation, finding they aged normally but showed earlier cellular senescence. Combined WRN and p53 mutations increased mortality, suggesting gene synergy in aging.
Area of Science:
- Genetics
- Molecular Biology
- Aging Research
Background:
- Werner's syndrome (WS) is a human premature aging disorder.
- The WRN gene, encoding a DNA helicase, is implicated in WS.
- Understanding WRN's role in aging and DNA repair is crucial.
Purpose of the Study:
- To investigate the in vivo function of the WRN helicase domain.
- To create and characterize a mouse model with a specific WRN mutation.
- To explore the interplay between WRN and p53 in lifespan determination.
Main Methods:
- Generation of mice with a mutation truncating the WRN helicase domain.
- Phenotypic analysis of mutant mice, including lifespan and histological assessment.
- Cellular assays evaluating DNA damage sensitivity and senescence in mutant fibroblasts.
- Cross-breeding mutant mice with p53-deficient mice to assess genetic synergy.
Main Results:
- Mutant mice exhibited normal lifespan and no overt signs of accelerated aging.
- Fibroblast cells from mutant mice showed slightly earlier senescence.
- Cells displayed normal resistance to genotoxins like camptothecin and 4-NQO.
- Double mutant WRN(-/-);p53(-/-) mice had increased mortality compared to WRN(+/-);p53(-/-) controls.
Conclusions:
- The C-terminal helicase domain of WRN is not essential for preventing premature aging in mice.
- A synergistic interaction exists between WRN and p53 in regulating lifespan.
- This mouse model provides insights into the complex mechanisms of aging and DNA repair.